Registry for patients with spinal tumors undergoing surgery
Official title: Swiss Spinal Tumor Registry (Swiss-STR)
Run by Luzerner Kantonsspital · NCT06869746 · Data updated 2026-11-12
This study is collecting information from patients who have surgery for spinal tumors to see how well different treatments work and to improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Luzerner Kantonsspital Academic / other |
| Locations | 1 site (Lucerne, Canton of Lucerne) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2032 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT06869746 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older diagnosed with either primary or metastatic spinal tumors who are indicated for surgical treatment.
✕Probably not a fit
Patients under 18 years old or those who withdraw consent or from the planned surgical procedure may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Swiss Spinal Tumor Registry is a prospective registry that collects data on patients who have undergone surgical treatment for primary and metastatic spinal tumors. It aims to address the lack of robust clinical outcomes data by documenting various surgical interventions and their effectiveness. The registry will categorize clinical presentations of spinal tumors to inform treatment recommendations and assess the socio-economic impact of these conditions on healthcare. By gathering comprehensive data, the study seeks to improve the quality of care for patients with spinal tumors.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment guidelines and better patient outcomes for those with spinal tumors.
How similar studies have gone: Other registries and studies focusing on surgical outcomes for spinal tumors have shown promise in improving treatment protocols and patient care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of primary spinal tumor * Diagnosis of secondary (metastatic) spinal tumor * Indication for surgical treatment is present * Patient age: =/\>18 years Exclusion criteria: * Withdrawal of consent * Withdrawal from initially planned surgical procedure * Patient age: \<18 years
Where it's running
-
Lucerne Cantonal Hospital
Lucerne, Canton of Lucerne, Switzerland Recruiting
Study contacts
- Principal investigator: Edin Nevzati, MD
- Study coordinator: Edin Nevzati, MD
- Email: edin.nevzati@luks.ch
- Phone: +41412054504
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PMCF look at METROSAN spinal systems and BONEGRAFT materials in adults after spine surgery
This PMCF study tests the safety and performance of METROSAN Titania spinal systems and Bonegraft materials in adults undergoing spinal fusion or stabilization in routine practice.
-
Focused high-dose SBRT for spinal tumors
This program will try focused high-dose SBRT for adults with spinal metastases to track side effects and local tumor control during routine care.
-
Using brief electric fields during spine surgery to let CNS tumor markers into the blood
Try whether a short, targeted application of electric pulses during intradural spinal tumor surgery makes brain-derived proteins detectable in a blood sample for adults having this operation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.